Search
for
Sort by
Research 241–270 of 518
- Real-world evidence in alopecia areata treatment: A narrative review
- Hair follicle targeting via gelatin coated transferosomes loaded with tofacitinib citrate for enhanced treatment of alopecia areata: Clinical evaluation of alopecia areata patients
- Hair regrowth in a patient with alopecia universalis and psoriasis vulgaris during deucravacitinib therapy
- Efficacy and Tolerability of Brevilin-A, a Natural JAK Inhibitor, in Pediatric Alopecia Areata: A Case Series
- A Case of Vitiligo Combined with Systemic Lupus Erythematosus Treated with Tofacitinib
- Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata
- Baricitinib: Exploring the Safety Profile for the Treatment of Alopecia Areata
- Hair follicle immune privilege and its collapse in alopecia areata
- Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study
- Patterns of clinical response in patients with alopecia areata treated with ritlecitinib in the ALLEGRO clinical development programme
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- Immune therapies for alopecia areata: evidence and new perspectives
- Modelling Human Hair Follicles—Lessons from Animal Models and Beyond
- Ex Vivo Treatment with Allogenic Mesenchymal Stem Cells of a Healthy Donor on Peripheral Blood Mononuclear Cells of Patients with Severe Alopecia Areata: Targeting Dysregulated T Cells and the Acquisition of Immunotolerance
- Recent Advances in Drug Development for Hair Loss
- Modulating immune responses in alopecia: therapeutic insights and potential targets of antisense oligonucleotides
- The Involvement of RIPK1 in Alopecia Areata
- Astilbin Activates the Reactive Oxidative Species/PPARγ Pathway to Suppress Effector CD4+ T Cell Activities via Direct Binding With Cytochrome P450 1B1
- JAK Inhibitors for Treatment of Alopecia Areata
- Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention
- Age-associated inflammation connects RAS-induced senescence to stem cell dysfunction and epidermal malignancy
- Resident Memory T Cells in Autoimmune Skin Diseases
- New and Emerging Therapies for Alopecia Areata
- Evaluation of the level of serum Interleukins (IL-2, IL-4, IL-15 andIL-17) and its relationship with disease severity in patients with alopecia areata
- Human umbilical cord mesenchymal stem cell treatment alleviates symptoms in an atopic dermatitis-like mouse model
- Frontal Fibrosing Alopecia. An Example of Disrupted Aryl Hydrocarbon Receptor-Mediated Immunological Homeostasis in the Skin?
- Janus kinase inhibitors for alopecia areata
- Case report: Psoriasiform eczema with immune-mediated comorbidities treated with upadacitinib
- A review of Janus kinase inhibitor use in scarring alopecia